| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.022 | 0.8 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.0094 | 0.8 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | 0.032 | 0.8 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.044 | 0.8 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.8 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.8 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.011 | 0.8 |